Patients with medication-refractory temporal lobe epilepsy may benefit substantially from surgery, researchers affirmed.

Day one, hear the industry leaders discuss navigating the health care system for patients, purchasers, and providers to achieve an optimal result. Interactive panel discussions will address the financial, legal, and social responsibilities of providers, manufacturers, and payers when considering coverage for new drugs and medical devices, and what to do when a product is recalled.
continue reading

High quality CME and awesome skiing. Dynamic Australian based faculty. Paediatric Emergency and Critical Care themes. Accredited for MOPs points.

The 2009 Biomanufacturing Summit brings together world class leaders within biopharmaceuticals to explore the dynamic strategies, benchmark the latest technologies and analyze the most cutting edge science.

This is a self report CME credit program. Up to 26.5 AMA PRA Category 1 CreditsTM will be given.

Organized by: The University of Utah School of Medicine • Department of Internal Medicine Deadline for abstracts/proposals: Not available.

This two-day course will be most valuable to medical device software engineers, engineering managers, scientists, and quality engineers (particularly in product development). This course will also be beneficial to quality assurance and regulatory affairs personnel who are new to the industry or their current position and do not have an in-depth knowledge of Medical Device Software requirements.
continue reading

Overview of the Australian Synchrotron's Imaging and Medical Therapy Beamline

This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment of cancer-related pain, using a novel gene transfer vector injected into the skin to deliver a pain-relieving gene to the nervous system.

The new treatment--magnetic resonance imaging (MRI)-guided transurethral ultrasound--uses heat from focused ultrasound to treat cancer in the prostate gland precisely while sparing the delicate noncancerous tissues around the prostate essential for healthy urinary, bowel and sexual function.

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015.

BSD Medical Corporation today reported that a new article in Current Option in Oncology highlights strong success from the use of the BSD-2000 manufactured by BSD Medical Corporation, in treating patients with high risk soft tissue sarcomas.

Dr. Bradley Monk, a UC Irvine gynecologic oncologist who led the worldwide phase III clinical trial, said trabectedin is the most recent addition to a short list of active drug therapies for recurrent ovarian cancer. He presents study results Sept. 15 at the 33rd Congress of the European Society for Medical Oncology in Stockholm.

Now a study from the University of North Carolina at Chapel Hill School of Medicine suggests that molindone, a first-generation drug, is as effective as the newer ones and should be used as a first line of therapy in some children with schizophrenia or schizoaffective disorder.

continue reading

Bayer HealthCare Pharmaceuticals Inc. today announced that Betaseron(R)* (interferon beta-1b), its treatment for relapsing forms of multiple sclerosis (MS), will soon be available with a new 30-gauge needle, which will be the thinnest needle of any injectable disease-modifying therapy for people with MS. The new needle is as thin as the needle commonly used for insulin and pediatric injections.

Read Entire Article

Can patients be charged for a therapy that is still under research? Can they be forced to make payments even though they have seen no result with the therapy? Is stem cell therapy more hype than hope?

In an interaction with Dr Alok Srivatsava, head of department of haematology, students of Stanley Medical College raised several issues in an attempt to bring stem cell therapy out of the shadows. The deeper they got into the discussion , the more convinced they got about the need for legislation to regulate stem cell therapy.

continue reading